Not recruitingEUCTR 2009-012003-26
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
This historical record does not confirm current site availability.
Historical research recordMultiple countriesBipolarity
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Belgium · Greece and 1 more location
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- 350
- Sponsor
- Janssen-Cilag International, NV
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Belgium, Greece, Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2009-012003-26
- Official title
Show the full official title
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belgium · Greece · Netherlands
Registry details
Historical country statuses
- Belgium — Prematurely Ended
- Greece — Completed
- Netherlands — Prematurely Ended
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Cilag International, NV.
Is this study still recruiting?
The historical registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Effects of personalized exercise training on physical activity, health-related fitness, sleep quality, and quality of life among middle-aged and older adults with multiple health problems
Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder, a randomized controlled trial. The Laborit study.